• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤维蛋白对人脐静脉内皮细胞纤溶酶原激活物抑制剂1释放的抑制作用。

Suppression of plasminogen activator inhibitor 1 release by fibrin from human umbilical vein endothelial cells.

作者信息

Fukao H, Ueshima S, Tanaka N, Okada K, Matsuo O

机构信息

Department of Physiology, Kinki University School of Medicine, Osaka, Japan.

出版信息

Thromb Res Suppl. 1990;10:11-20. doi: 10.1016/0049-3848(90)90374-l.

DOI:10.1016/0049-3848(90)90374-l
PMID:2107596
Abstract

The effect of fibrin stimulation on the fibrinolytic potential in cultured human umbilical vein endothelial cells (HUVEC) was investigated in the normal state and aged state. The amount of antigen of the two fibrinolytic factors, tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1), was determined using ELISA and the ABC method, respectively. When a fibrin clot was overlayered on the normal HUVEC, the secretion of t-PA or PAI-1 from the HUVEC was greatly changed. That is, PAI antigen was decreased 3-fold and t-PA antigen increased slightly in the conditioned medium. On the other hand, when the aged HUVEC were stimulated by a fibrin clot, PAI antigen was increased 3-fold and t-PA antigen did not change in the conditioned medium. When the level of fibrinolytic activity in the conditioned medium was expressed as the molar ratio of PAI and t-PA (PAI/t-PA), the value in the fibrin-stimulated normal HUVEC was markedly reduced (a 3.5-fold decrease) when compared with that of the non-stimulated normal HUVEC, reflecting a profibrinolytic state. On the other hand, the value in the fibrin-stimulated aged HUVEC was markedly increased (a 5-fold increase) when compared with that of the non-stimulated aged HUVEC, reflecting an antifibrinolytic state. Actinomycin D- or cycloheximide-treated HUVEC showed no response to the fibrin stimulation. We conclude that the level of HUVEC-mediated fibrinolytic activity was regulated mainly by the production and secretion of PAI from the HUVEC to protect against the generation of thrombi. In the aged HUVEC, the regulatory mechanism acts in an opposite manner and a thrombotic process may be induced.

摘要

研究了纤维蛋白刺激对正常状态和衰老状态下培养的人脐静脉内皮细胞(HUVEC)纤溶潜能的影响。分别采用ELISA法和ABC法测定了两种纤溶因子,即组织型纤溶酶原激活物(t-PA)和纤溶酶原激活物抑制剂1(PAI-1)的抗原量。当在正常HUVEC上覆盖纤维蛋白凝块时,HUVEC中t-PA或PAI-1的分泌发生了很大变化。也就是说,条件培养基中PAI抗原减少了3倍,t-PA抗原略有增加。另一方面,当衰老的HUVEC受到纤维蛋白凝块刺激时,条件培养基中PAI抗原增加了3倍,t-PA抗原没有变化。当将条件培养基中的纤溶活性水平表示为PAI与t-PA的摩尔比(PAI/t-PA)时,与未刺激的正常HUVEC相比,纤维蛋白刺激的正常HUVEC中的该值显著降低(降低了3.5倍),反映出纤溶状态。另一方面,与未刺激的衰老HUVEC相比,纤维蛋白刺激的衰老HUVEC中的该值显著增加(增加了5倍),反映出抗纤溶状态。用放线菌素D或环己酰亚胺处理的HUVEC对纤维蛋白刺激无反应。我们得出结论,HUVEC介导的纤溶活性水平主要受HUVEC中PAI的产生和分泌调节,以防止血栓形成。在衰老的HUVEC中,调节机制以相反的方式起作用,可能会诱导血栓形成过程。

相似文献

1
Suppression of plasminogen activator inhibitor 1 release by fibrin from human umbilical vein endothelial cells.纤维蛋白对人脐静脉内皮细胞纤溶酶原激活物抑制剂1释放的抑制作用。
Thromb Res Suppl. 1990;10:11-20. doi: 10.1016/0049-3848(90)90374-l.
2
Induction of synthesis of plasminogen activator inhibitor type-1 by tissue-type plasminogen activator in human hepatic and endothelial cells.组织型纤溶酶原激活物在人肝细胞和内皮细胞中诱导1型纤溶酶原激活物抑制剂的合成。
Thromb Haemost. 1990 Nov 30;64(3):412-9.
3
The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator.与培养的人内皮细胞相关的大多数1型纤溶酶原激活物抑制剂位于细胞下方,并且可被液相组织型纤溶酶原激活物作用。
J Cell Biol. 1990 Jan;110(1):155-63. doi: 10.1083/jcb.110.1.155.
4
Interaction of tissue-type plasminogen activator and plasminogen activator inhibitor 1 on the surface of endothelial cells.组织型纤溶酶原激活剂与纤溶酶原激活剂抑制剂1在内皮细胞表面的相互作用。
J Biol Chem. 1988 Feb 5;263(4):1960-9.
5
Sphingomyelinase and cell-permeable ceramide analogs increase the release of plasminogen activator inhibitor-1 from cultured endothelial cells.
Thromb Res. 1995 Dec 15;80(6):509-18. doi: 10.1016/0049-3848(95)00206-5.
6
Synthesis and secretion of plasminogen activator inhibitor 1 by human endothelial cells in vitro. Effect of active site mutagenized tissue-type plasminogen activator.人内皮细胞在体外合成及分泌纤溶酶原激活物抑制剂1。活性位点诱变的组织型纤溶酶原激活物的作用。
J Biol Chem. 1991 Jan 15;266(2):792-7.
7
Determinants of induction of increased synthesis of plasminogen activator inhibitor type-1 in human endothelial cells by t-PA.组织型纤溶酶原激活物诱导人内皮细胞中1型纤溶酶原激活物抑制剂合成增加的决定因素。
Thromb Haemost. 1992 Feb 3;67(2):233-8.
8
Effects of fibrin on the secretion of plasminogen activator inhibitor-1 from endothelial cells and on protein kinase C.
Life Sci. 1995;57(13):1267-76. doi: 10.1016/0024-3205(95)02083-u.
9
Interaction of wild-type and catalytically inactive mutant forms of tissue-type plasminogen activator with human umbilical vein endothelial cell monolayers.组织型纤溶酶原激活剂的野生型和催化失活突变体形式与人脐静脉内皮细胞单层的相互作用。
J Biol Chem. 1990 Feb 15;265(5):2755-62.
10
Binding of tissue-type plasminogen activator with human endothelial cell monolayers. Characterization of the high affinity interaction with plasminogen activator inhibitor-1.组织型纤溶酶原激活剂与人内皮细胞单层的结合。与纤溶酶原激活剂抑制剂-1高亲和力相互作用的表征。
J Biol Chem. 1990 Feb 15;265(5):2569-75.